Factors such as dosing frequency, route of administration (injectable or oral), and potential side effects may influence the selection process
The premise is not fully settled: No endogenous MGF peptide has been isolated in vivo, and synthetic MGFs effects differ from known IGF-1 products so claims about its physiological role should be read with genuine caution [1]
The resource includes step-by-step instructions for each process, definitions, contact information, and more
In short, they found that while consumers, employers and physicians are optimistic about the effectiveness of GLP-1s to treat obesity, cost and coverage are significant hurdles for consumer access
The highest risk appears to be in patients with type 2 diabetes who have established diabetic retinopathy at the time of treatment initiation, particularly when aggressive glycemic targets are pursued rapidly without appropriate ophthalmologic monitoring